Trials / Completed
CompletedNCT02512653
Biological Standarization of Cupressus Arizonica Allergen Extract to Determine the Biological Activity in Histamine Equivalent Units (HEP)
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 33 (actual)
- Sponsor
- Laboratorios Leti, S.L. · Industry
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
Biological Standardization of Cupressus arizonica Allergen Extract.
Detailed description
This is an open, unblinded and non-randomized biological assay. The study design is a slight modification of the recommendations proposed by the Nordic Guidelines.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Cupressus arizonica | Four different concentrations of Cupressus arizonica allergen extract, positive control and negative control |
Timeline
- Start date
- 2015-11-01
- Primary completion
- 2015-12-01
- Completion
- 2016-01-01
- First posted
- 2015-07-31
- Last updated
- 2016-06-20
Locations
2 sites across 1 country: Spain
Source: ClinicalTrials.gov record NCT02512653. Inclusion in this directory is not an endorsement.